Quercis Pharma - Crunchbase Company Profile & Funding

Q: Where is Quercis Pharma's headquarters?

Quercis Pharma is located in Zug, Zug, Switzerland.

Q: When was the last funding round for Quercis Pharma?

Quercis Pharma closed its last funding round on obfuscated from a Private Equity round.

Q: How much funding has Quercis Pharma raised to date?

Quercis Pharma has raised obfuscated.

Overview

Quercis Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Quercis Pharma

CB Rank

54196

Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases.

Founded

obfuscation

Private

Private Equity

Zug, Zug, Switzerland

11-50

www.quercis.com/

Biopharma

Biotechnology

Life Science

Medical

Pharmaceutical

Funding Rounds

Private Equity

OBF

obfuscation

Key People

Stefan Wohlfeil: Chief Medical Officer
Thomas Lines: Founder, CEO and Director

Details

Legal Name

Quercis Pharma AG

Operating Status

Active

Company Type

For Profit

About the Company

Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases. It is advancing a development pipeline of late-stage clinical studies that focus on the prevention of VTE in cancer patients. In addition, Quercis targets other diseases associated with thrombotic events, such as sickle cell

disease (SCD), Ebola, and COVID-19. The Company’s lead drug candidate acts as an antithrombotic with a significantly lower risk of adverse events than existing treatments.

The company was founded in 2019 and is based in Zug, Switzerland.

Contact Email

info@quercis.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Kinisoquin™

An orally available drug candidate designed to prevent venous thrombosis and pulmonary embolism in high-risk cancer patients.

Combination drug of Isoquercetin and Zafirlukast

A Phase 2 ready combination drug candidate targeting cancer and neurological diseases by modulating immune and thrombotic pathways.

Research & Development

Quercis Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Quercis Pharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Private Equity
obfuscated obfuscation	Private Equity Round - Quercis Pharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Private Equity
obfuscated obfuscation	Private Equity Round - Quercis Pharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Private Equity
obfuscated obfuscation	Private Equity Round - Quercis Pharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Private Equity
obfuscated obfuscation	Private Equity Round - Quercis Pharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Private Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Quercis Pharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Private Equity
obfuscated obfuscation	Private Equity Round - Quercis Pharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Private Equity
obfuscated obfuscation	Private Equity Round - Quercis Pharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Private Equity
obfuscated obfuscation	Private Equity Round - Quercis Pharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Private Equity
obfuscated obfuscation	Private Equity Round - Quercis Pharma	1	obfuscated obfuscation	The Global Emerging Markets Group	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
The Global Emerging Markets Group	Yes	Private Equity Round - Quercis Pharma	—
The Global Emerging Markets Group	Yes	Private Equity Round - Quercis Pharma	—
The Global Emerging Markets Group	Yes	Private Equity Round - Quercis Pharma	—
The Global Emerging Markets Group	Yes	Private Equity Round - Quercis Pharma	—
The Global Emerging Markets Group	Yes	Private Equity Round - Quercis Pharma	—